Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Qualio Reviews & Ratings
    4.4 out of 5 stars 919 Ratings
    Company Website for Qualio
  • FrameworkLTC Reviews & Ratings
    4.4 out of 5 stars 48 Ratings
    Company Website for FrameworkLTC
  • SDS Manager Reviews & Ratings
    5.0 out of 5 stars 4 Ratings
    Company Website for SDS Manager
  • ChatD&B Reviews & Ratings
    Company Website for ChatD&B
  • Maintenance Care Reviews & Ratings
    4.7 out of 5 stars 297 Ratings
    Company Website for Maintenance Care
  • Predict360 Reviews & Ratings
    4.7 out of 5 stars 18 Ratings
    Company Website for Predict360
  • Bluepear Reviews & Ratings
    4.8 out of 5 stars 79 Ratings
    Company Website for Bluepear
  • Lockbox LIMS Reviews & Ratings
    4.8 out of 5 stars 72 Ratings
    Company Website for Lockbox LIMS
  • Jotform Reviews & Ratings
    4.6 out of 5 stars 9,009 Ratings
    Company Website for Jotform
  • CoachIQ Reviews & Ratings
    4.9 out of 5 stars 45 Ratings
    Company Website for CoachIQ

What is PharmaPendium?

PharmaPendium is a comprehensive resource that provides users with access to a wide range of drug approval documents from the FDA and EMA, covering crucial elements such as pharmacokinetics, pharmacodynamics, and safety assessments. This platform offers valuable insights into drug interactions, adverse effects, and clinical trial outcomes, enabling stakeholders to make informed decisions in both drug development and regulatory submissions. Its extensive database supports researchers and healthcare professionals in evaluating the safety and effectiveness of various medications, thereby playing a critical role in advancing pharmaceutical research and improving patient care. Users can also investigate historical regulatory submissions and utilize previous cases to gain a clearer insight into agency expectations. The user-friendly interface facilitates an easy transition from raw data to engaging visual representations like charts and graphs, enhancing the analysis and interpretation of results. Furthermore, the platform allows users to search for information on adverse events (MedDRA), therapeutic targets, drug indications, and endpoints through standardized data. Result pages effectively link preclinical research with clinical applications, offering a holistic view of the drug development ecosystem. Overall, PharmaPendium not only simplifies the research process but also encourages collaboration and knowledge exchange among professionals in the industry, ultimately contributing to better health outcomes. The array of features offered by this platform makes it an invaluable tool for those involved in the pharmaceutical field.

What is CoVigilAI?

CoVigilAI represents a state-of-the-art innovation in the realm of medical literature monitoring, harnessing the power of artificial intelligence and advanced data analytics to proactively detect and manage adverse drug reactions, ensuring patient safety and compliance with regulatory requirements in real-time. This platform facilitates the efficient tracking of scientific and medical literature by retrieving data from prominent global databases such as PubMed and Embase, and it offers customizable search options that improve the pharmacovigilance literature review process. Furthermore, it conducts thorough evaluations of scientific articles and publications from various regional journals, guaranteeing an extensive oversight of both global and localized literature. With the implementation of sophisticated algorithms, the system categorizes Individual Case Safety Reports (ICSRs) into three distinct classifications: valid, potential, and invalid cases, while its automated key entity recognition feature proficiently pinpoints critical components such as patients, medications, adverse reactions, and pertinent medical events. This comprehensive strategy not only streamlines the monitoring procedure but also considerably boosts the precision and efficiency of drug safety evaluations, contributing to a safer healthcare environment. Ultimately, CoVigilAI serves as an indispensable tool for enhancing drug safety and fostering informed decision-making in the medical field.

Media

Media

Integrations Supported

Integrations Supported

Embase
PubMed

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Standard Support
Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Documentation Hub
Online Training
On-Site Training

Training Options

Documentation Hub
Online Training
On-Site Training

Company Facts

Organization Name

Elsevier

Date Founded

1880

Company Location

Netherlands

Company Website

www.elsevier.com/products/pharmapendium

Company Facts

Organization Name

CoVigilAI

Company Location

India

Company Website

covigilai.in/

Categories and Features

Pharmacovigilance

Not specified

Categories and Features

AI Science

Not specified

Pharmacovigilance

Not specified

Popular Alternatives

Popular Alternatives

Embase Reviews & Ratings

Embase

Elsevier
Dialog Reviews & Ratings

Dialog

Clarivate